Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
India · Delayed Price · Currency is INR 527.30
-11.30 (-2.10%)
Jul 22, 2026, 3:30 PM IST
Amrutanjan Health Care Revenue
In the fiscal year ending March 31, 2026, Amrutanjan Health Care had annual revenue of 5.03B INR with 11.19% growth. Amrutanjan Health Care had revenue of 1.50B in the quarter ending March 31, 2026, with 10.48% growth.
Revenue
5.03B
Revenue Growth
+11.19%
P/S Ratio
3.10
Revenue / Employee
6.82M
Employees
737
Market Cap
15.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.03B | 505.89M | 11.19% |
| Mar 31, 2025 | 4.52B | 305.93M | 7.26% |
| Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
| Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
| Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Solara Active Pharma Sciences | 13.69B |
| Windlas Biotech | 9.04B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 6.41B |
| Sigachi Industries | 4.86B |
| Beta Drugs | 3.85B |
Amrutanjan Health Care News
- 4 weeks ago - Amrutanjan Health Care secures approval for director appointments via postal ballot - Business Upturn
- 2 months ago - Amrutanjan Health Care appoints Ramaswami Krishnan to key committee roles - Business Upturn
- 9 months ago - Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm in Classic Glass Packaging - Business Upturn